BMS 182193
structure in first source
Also Known As:
BMS 182,193; BMS-182,193; BMS-182193
Networked: 1
relevant articles (0 outcomes,
1 trials/studies)
Bio-Agent Context: Research Results
Related Diseases
| 1. | Infections
02/01/1995
- " Time-of-addition studies indicated that BMS 182,193 could be added as late as 27 h after infection and still retain its antiviral activity. " 02/01/1995
- " BMS 182,193, BMS 186,318, and BMS 187,071 protected cells against HIV-1, HIV-2, and simian immunodeficiency virus infections, with 50% effective doses ranging from 0.05 to 0.33 microM, while having no inhibitory effect on cells infected with unrelated viruses. "
|
|
Related Drugs and Biologics